This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Procalcitonin in Pleural Pleuritis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier:
NCT01011881
First received: November 10, 2009
Last updated: June 8, 2016
Last verified: June 2016
  Purpose
The purpose of this study is to determine pleural level of procalcitonin in differents situations of pleuritis.

Condition Intervention
Pleuritis Pleural Empyema Other: pleural level of procalcitonin

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation de la Mesure du Taux de la Procalcitonine Dans Les Liquides Pleuraux

Further study details as provided by Centre Hospitalier Universitaire, Amiens:

Enrollment: 34
Study Start Date: October 2009
Study Completion Date: February 2011
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
patients with pleuritis Other: pleural level of procalcitonin
no intervention

Detailed Description:

Determine pleural level of procalcitonin in pleuritis. Two periods First period evaluation in vitro study/ Determine adequat technique included type of samples tubes for adequat analysis.

Second periods : Patient with pleuritis . Empyema or not

  Eligibility

Ages Eligible for Study:   18 Years to 99 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with pleuritis
Criteria

Inclusion Criteria:

  • Pleuritis
  • Hospitalisation

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01011881

Locations
France
CHU Amiens
Amiens, France, 80000
Sponsors and Collaborators
Centre Hospitalier Universitaire, Amiens
  More Information

Responsible Party: Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier: NCT01011881     History of Changes
Other Study ID Numbers: PI09-DR-DOUADI
Study First Received: November 10, 2009
Last Updated: June 8, 2016

Keywords provided by Centre Hospitalier Universitaire, Amiens:
pleuritis
empyema
procalcitonin

Additional relevant MeSH terms:
Empyema
Empyema, Pleural
Pleurisy
Suppuration
Infection
Inflammation
Pathologic Processes
Respiratory Tract Infections
Pleural Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on July 25, 2017